| Website | aquapharm.co.uk |
| Category | BioTech |
| Phone | 44-(0)-1631-559-393 |
| enquiries@aquapha... | |
| Employees | |
| Founded | 2000 |
| TOTAL | $16.2M |
| FUNDING TOTAL | $16.2M |
| Series B, 8/05 Scottish Enterprise, Investment Arm E-Synergy | $1.61M |
| Series B, 7/07 Aescap Venture Tate & Lyle Ventures Scottish Enterprise, Investment Arm NESTA Investments H.I.E. Argyll | £4M |
| Series C, 4/10 Aescap Venture Tate & Lyle Ventures Highlands and Islands Enterprise NESTA Investments | $6.4M |
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm’s development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
